source
- Exclusive: Obesity biotech Verdiva hires ex-Metsera CMO as crucial readouts nearLong-acting obesity pill developer Verdiva Bio has a new chief medical officer, and he comes from a biotech that was looking at very similar technology — and got bought for $10 billion not long ago…Endpoints · 8d ago↗ source
- Scancell to go public after winning reverse merger bid for troubled NeuphoriaScancell and Neuphoria have made their union official via a reverse merger that will result in a Nasdaq listing for Scancell and a resolution for Neuphoria’s shareholders after the biotech ended it…Fierce Biotech · 8d ago↗ source
- Teladoc is moving beyond its single-visit roots with new launchOver two decades ago, Teladoc built its business around quick doctor visits that didn't happen in person. Now, it's saying that the model of one-off virtual appointments is no longer enough. The te…